Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof
US-2021363105-A1 · Nov 25, 2021 · US
Abide Therapeutics Inc holds 14 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 14 |
| Recent patents | 0 |
| First publication | Jan 15, 2015 |
| Latest publication | Nov 25, 2021 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2021363105-A1 · Nov 25, 2021 · US
US-11053199-B2 · Jul 6, 2021 · US
US-2020095201-A1 · Mar 26, 2020 · US
US-10093630-B2 · Oct 9, 2018 · US
US-2018208568-A1 · Jul 26, 2018 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2021363105-A1 · Nov 25, 2021 · US
US-11053199-B2 · Jul 6, 2021 · US
US-2020095201-A1 · Mar 26, 2020 · US
US-10093630-B2 · Oct 9, 2018 · US
US-2018208568-A1 · Jul 26, 2018 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 14 |
| Human Necessities | 12 |
Answers are generated from the same data shown on this page.